Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

BTA-585 enters phase IIa trial for the treatment of RSV infections

April 12, 2016

Encouraging results seen in phase II murepavadin study

April 12, 2016

Data reported from phase III study of surotomycin for CDAD

April 12, 2016

Immunogenicity and safety of MG-1109

April 12, 2016

FDA grants fast track status for Carbavance

April 12, 2016

Human Vaccines Project announces Mesa Consortium

April 11, 2016

Researchers present novel murine models to study Zika virus

April 11, 2016

Two-antibody cocktail MIL77E protects primates from Ebola virus

April 11, 2016

Immunovaccine and Leidos to collaborate on a Zika virus vaccine candidate

April 8, 2016

Changzhou Yinsheng Pharmaceutical and Sichuan University patent HCV NS4B inhibitors

April 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...